293 related articles for article (PubMed ID: 35772577)
1. 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
Radiother Oncol; 2022 Sep; 174():37-43. PubMed ID: 35772577
[TBL] [Abstract][Full Text] [Related]
2. Role of 21-Gene Recurrence Score in Predicting Prognostic Benefit of Radiation Therapy After Breast-Conserving Surgery for T1N0 Breast Cancer.
Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
Pract Radiat Oncol; 2023; 13(3):e230-e238. PubMed ID: 36038115
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study.
Hung SK; Yang HJ; Lee MS; Liu DW; Chen LC; Chew CH; Lin CH; Lee CH; Li SC; Hong CL; Yu CC; Yu BH; Hsu FC; Chiou WY; Lin HY
Breast Cancer Res; 2023 Dec; 25(1):149. PubMed ID: 38066611
[TBL] [Abstract][Full Text] [Related]
4. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
[TBL] [Abstract][Full Text] [Related]
5. Survival Comparisons between Breast Conservation Surgery and Mastectomy Followed by Postoperative Radiotherapy in Stage I-III Breast Cancer Patients: Analysis of the Surveillance, Epidemiology, and End Results (Seer) Program Database.
Xiang W; Wu C; Wu H; Fang S; Liu N; Yu H
Curr Oncol; 2022 Aug; 29(8):5731-5747. PubMed ID: 36005190
[TBL] [Abstract][Full Text] [Related]
6. The effect of adjuvant radiotherapy after breast-conserving surgery in elderly women with T1-2N0 estrogen receptor-negative breast cancer.
Chen C; Wang R; Wang B; Wu Y; Jiang J
PLoS One; 2023; 18(8):e0288078. PubMed ID: 37535561
[TBL] [Abstract][Full Text] [Related]
7. 21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal breast cancer after breast-conserving surgery.
Xie SJ; Wang RJ; Wu SG; Zhang FX
Breast; 2024 Apr; 74():103679. PubMed ID: 38367283
[TBL] [Abstract][Full Text] [Related]
8. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
9. Successful management of elderly breast cancer patients treated without radiotherapy.
Valassiadou K; Morgan DA; Robertson JF; Pinder SE; Cheung KL
World J Surg Oncol; 2007 Jun; 5():62. PubMed ID: 17543132
[TBL] [Abstract][Full Text] [Related]
10. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L
Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071
[TBL] [Abstract][Full Text] [Related]
11. Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan.
Tang L; Ma Z; Ishikawa Y; Matsushita H; Ishida T; Jingu K
Breast Cancer; 2021 Mar; 28(2):465-470. PubMed ID: 33141399
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of radiotherapy in low-risk elderly breast cancer patients after breast-conserving surgery: a cohort study.
Lai X; Han W; Zhang H; Hou J; Wang G; Luo X; Li X; Wang Q; Zhang Y; Wang H; Li Y
Gland Surg; 2022 May; 11(5):847-859. PubMed ID: 35694094
[TBL] [Abstract][Full Text] [Related]
13. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
[TBL] [Abstract][Full Text] [Related]
14. The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study.
Xia LY; Xu WY; Hu QL
PLoS One; 2021; 16(9):e0256893. PubMed ID: 34473783
[TBL] [Abstract][Full Text] [Related]
15. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma.
Chevli N; Wang K; Haque W; Schwartz MR; Nangia J; Sasaki J; Farach AM; Hatch SS; Butler EB; Teh BS
Clin Breast Cancer; 2022 Oct; 22(7):e807-e817. PubMed ID: 35915020
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
18. Omitting Adjuvant Radiotherapy for Hormone Receptor‒Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis.
Kim YJ; Shin KH; Kim K
Cancer Res Treat; 2019 Jan; 51(1):326-336. PubMed ID: 29747486
[TBL] [Abstract][Full Text] [Related]
19. Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy.
Pece S; Sestak I; Montani F; Tillhon M; Maisonneuve P; Freddi S; Chu K; Colleoni M; Veronesi P; Disalvatore D; Viale G; Buus R; Cuzick J; Dowsett M; Di Fiore PP
Eur J Cancer; 2022 Mar; 164():52-61. PubMed ID: 35172273
[TBL] [Abstract][Full Text] [Related]
20. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]